ISS Joins Glass Lewis in Urging Parkland Shareholders to Vote For Meaningful Change
Article content
Simpson Oil Reminds Shareholders to Visit www.RefuelParkland.com for Details on How to Vote for All Nine of Simpson Oil's Director Candidates on the GOLD Proxy Card Ahead of May 6 AGM
Article content
GRAND CAYMAN, Cayman Islands — Simpson Oil Limited ('Simpson Oil', 'we' or 'our'), the largest shareholder of Parkland Corporation ('Parkland' or the 'Company'), holding 19.8% of the outstanding common shares, today announced that Institutional Shareholder Services Inc. ('ISS') has joined Glass, Lewis & Co. ('Glass Lewis') in recommending that Parkland shareholders support significant change by voting for six of its nine director nominees at the Company's Annual General Meeting (the 'Meeting' or the 'AGM') to be held on May 6, 2025.
Article content
ISS has recommended that shareholders vote the GOLD proxy card to elect Monty Baker, Michael Christiansen, Chris Folan, Brian Gibson, Darcy Morris, and Karen Stuckey to the Board of Directors (the 'Board').
Article content
Both ISS and Glass Lewis delivered scathing assessments of the current Board and its prolonged track record of underperformance and value destruction. In recommending the GOLD proxy card, ISS noted:
Article content
'…it is paradoxical that the board would concede a compelling case for change, as evidenced by the planned resignation of the company's CEO, commencement of a strategic review, and recommendation for three dissident nominees, while asserting that PKI (and not shareholders) should control how many, and which dissident nominees should be elected.'
Article content
On governance, ISS criticized the Board's handling of CEO succession, noting:
Article content
'The board's actions with respect to CEO succession in the last year are troubling in view of the fact that little evidence exists robust CEO succession planning measures were implemented, including an evaluation of external CEO prospects, during a pivotal year for CEO performance.'
Article content
Both proxy advisors also flagged 'grave' governance concerns, citing entrenched behaviors and persistent gamesmanship. ISS concluded:
Article content
'In short, the board has displayed a troubling pattern of decision-making aimed at thwarting the dissident. This has been reflected in the board's treatment of the dissident, in the board's persistent gamesmanship, and in the board's failure to proactively address leadership and other critical matters. These and other decisions have come at a steep cost to shareholders.'
Article content
ISS also underscored that responsibility for these governance failures extends to key members of the current Board:
Article content
'[Chair Michael] Jennings served alongside [Richard] Hookway and [Nora] Duke on the [governance and ethics] committee over the past year, meaning that all three bear some responsibility for PKI's deficient corporate governance.'
Article content
In light of the above commentary, Simpson Oil reiterates the urgent need for wholesale change and the election of all NINE of its highly qualified nominees. Michael Jennings is clearly accountable for the reactive behaviour of the Board as a whole and its efforts to prevent Simpson Oil from exercising its basic shareholder rights—the tone comes from the top. Furthermore, with the selection of Chris Folan by both ISS and Glass Lewis, there is no justification for retaining legacy director James Neate.
Article content
Finally, given the Board's history of flawed governance practices, we caution the Company from deploying any tactics that could delay the Meeting and/or compromise the integrity of the shareholder vote.
Article content
Simpson Oil reiterates that only the election of ALL NINE of its highly qualified nominees will deliver the fresh leadership, governance, and accountability shareholders deserve.
Article content
VOTE TODAY: Please ensure your GOLD form of proxy or VIF is received by the proxy voting deadline of May 1, 2025, at 5:00pm Mountain Time.
Article content
If you would like to vote shares that you hold in your Employee Share Purchase Plan (ESPP), if you have not received your Voting Instruction Form (VIF) by mail, or if you need help voting the GOLD proxy, please contact Carson Proxy, at 1-800-530-5189 (North America Toll Free), 416-751-2066 (Local and Text), or by email at info@carsonproxy.com.
Article content
Article content
Article content
Article content
Contacts
Article content
Media Enquiries
Longacre Square Partners
Amy Freedman / Andy Radia
SimpsonOil@longacresquare.com
Article content
Article content
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
a day ago
- Cision Canada
WESTERN COPPER ANNOUNCES ELECTION OF DIRECTORS AND VOTING RESULTS FROM ANNUAL SHAREHOLDERS' MEETING
VANCOUVER, BC, June 13, 2025 /CNW/ - Western Copper and Gold Corporation ("Western" or the "Company") (TSX: WRN) (NYSE American: WRN) announces the voting results from the Company's Annual General Meeting ("AGM") held on June 12, 2025. A total of 99,165,184 common shares were represented at the AGM, accounting for 49.58% of the votes attached to all outstanding common shares as of the record date. Detailed results of the vote for the election of directors and the appointment of the auditor are set out below. Voting results for the election of each of the directors are as follows: Voting results for the appointment of PricewaterhouseCoopers LLP as the auditor are as follows: The Company's report of voting results will be available on SEDAR ( EDGAR ( and on the Company's website. ABOUT WESTERN COPPER AND GOLD CORPORATION Western Copper and Gold Corporation is developing the Casino Project, Canada's premier copper-gold mine in the Yukon Territory and one of the most economic greenfield copper-gold mining projects in the world. The Company is committed to working collaboratively with our First Nations and local communities to progress the Casino Project, using internationally recognized responsible mining technologies and practices. For more information, visit On behalf of the board, "Sandeep Singh" Sandeep Singh President and CEO Western Copper and Gold Corporation Cautionary Note Regarding Forward-Looking Statements This news release includes certain "forward-looking information" and "forward-looking statements" (collectively "forward-looking statements") within the meaning of applicable Canadian and United States securities legislation including the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements are made as of the date of this news release. Forward-looking statements are frequently, but not always, identified by words such as "expects", "anticipates", "believes", "plans", "projects", "intends", "estimates", "envisages", "potential", "possible", "strategy", "goals", "opportunities", "objectives", or variations thereof or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative of any of these terms and similar expressions. Such forward-looking statements herein include statements regarding the anticipated advancement of the Casino Project, the continued support and involvement of Mitsubishi Materials, and the potential benefits of the extended investor rights agreement. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual events to be materially different from those expressed or implied by such statements. Such factors include but are not limited to the risk of unforeseen challenges in advancing the Casino project, potential impacts on operational continuity, changes in general market conditions that could affect the Company's performance; and other risks and uncertainties disclosed in the Company's annual information form and Form 40-F for the most recently completed financial year and its other publicly filed disclosure documents. Forward-looking statements are based on assumptions management believes to be reasonable, such assumptions and factors as set out herein, and in the Company's annual information form and Form 40-F for the most recently completed financial year and its other publicly filed disclosure document. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, other factors may cause results to be materially different from those anticipated, described, estimated, assessed or intended. These forward-looking statements represent the Company's views as of the date of this news release. There can be no assurance that any forward-looking statements will be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not intend to and does not assume any obligation to update forward-looking statements other than as required by applicable law.
Cision Canada
3 days ago
- Cision Canada
Michael Sabia to Leave Hydro-Québec to Take on New Challenges Français
MONTREAL, June 11, 2025 /CNW/ - Hydro-Québec President and Chief Executive Officer, Michael Sabia, informed the Chair of the Board, Manon Brouillette, that he will end his mandate on July 4 th to take on the role of Clerk of the Privy Council and Secretary to the Cabinet of the Government of Canada. « Hydro-Québec is at the heart of an energy and economic transition of the utmost importance for Québec. Over the last two years, Michael and his team have given our institution an ambitious and concrete plan to meet the challenges of this transition using the expertise and the professionalism of all our employees, highlighted Manon Brouillette. In addition to having diversified our renewable energy sources, he established genuine partnerships with Indigenous communities and our neighbours in Newfoundland and Labrador. On behalf of Hydro-Québec's directors, I thank Michael for his exceptional work and his leadership. I am confident that he will use his vast experience to serve our country well. » « Prime Minister Carney asked me to take on this role at a time when the country is facing some unprecedented challenges. In that context, I am joining the federal government to tackle these challenge head on, said Michael Sabia. When I arrived at Hydro-Québec, I was taken by Premier Legault's vision of Québec's energy and economic future, and the essential role Hydro-Québec needed to play in contributing to build that future. Today, I have full confidence that Hydro-Québec is on the right track. Eighteen months ago, we launched an ambitious plan. Thanks to talented people and devoted leaders, the organization is well underway to executing this plan, which includes a new agreement with Newfoundland and Labrador Hydro as well as the new foundations we are laying in our relationships with First Nations and the Inuit. I would like to thank the Chair of the Board, Manon Brouillette, as well as all directors for their support in launching the initiatives we have put in place. Most important, I would like to thank the 23 000 men and women of Hydro-Québec who are at the service of Quebecers every day. It's to all of you that I owe my gratitude for your dedication in building this great Québec institution. » Appointment of the next President and CEO In the coming weeks, the Board of Directors will identify a potential successor and will make a recommendation to the Government of Québec in order to nominate a leader to continue implementing Hydro-Québec's ambitious mission. All stakeholders can count on Hydro-Québec's seasoned executive team, which will continue to ensure the plan is being delivered.
Cision Canada
3 days ago
- Cision Canada
Specific Biologics Welcomes Paul J. Hastings as Chair of the Board of Directors
TORONTO, June 11, 2025 /CNW/ - Specific Biologics Inc., a biotechnology company advancing Dualase® genome editors for precise and programmable in vivo genome editing, today announced the appointment of Paul J. Hastings as Chair of its Board of Directors. Mr. Hastings is a distinguished leader in the biopharmaceutical industry and currently serves as Chief Executive Officer and Board Member of engineered cell therapy company Nkarta since 2018. He is also a current Director of EnGene, a non-viral gene therapy company, and recently served as the Chair of the Biotechnology Innovation Organization (BIO). Over his career, he has held numerous top leadership roles, including CEO of OncoMed, QLT, Axys Pharmaceuticals, and LXR Biotechnology, and President of Chiron BioPharmaceuticals. He has guided corporate strategy as Chair of Pacira Biosciences, Proteon Therapeutics and Proteolix, and as a Director of ViaCyte, Relypsa and ViaCell, and previously held leadership roles in global biotechnology companies as President of Genzyme Therapeutics Europe and Genzyme Global Therapeutics, as well as progressive executive roles at Hoffmann-La Roche. A committed mentor and patient advocate, he co-founded and chairs the board of Youth Rally Inc. and serves on the Board of the Termeer Foundation. "I am thrilled to welcome Paul to the Board," said Brent Stead, CEO of Specific Biologics. "His proven ability to lead and scale high-impact biotechnology companies with breakthrough technologies will be instrumental as we advance our Dualase® platform toward the clinic for patients in need. We are entering an exciting new phase of growth, and Paul's leadership of the Board will be invaluable." "I'm honored to join the Board of Specific Biologics at such a pivotal time," said Hastings. "The Dualase® technology has the potential to reshape how we approach treating some of the most challenging genetic diseases. I look forward to working with the leadership team and Board to support Specific's mission and drive meaningful impact for patients with limited therapeutic options." Specific Biologics also extends its sincere gratitude to Dr. Steven Kanner for his dedicated service on the Board and guidance during a critical phase of the company's development. "Steve played a key role in helping shape our early strategy and set the foundation for our current momentum," said Stead. About Specific Biologics Inc. Specific Biologics is a venture-backed biotechnology company developing Dualase®, an industry-leading genome editing platform for precise, efficient, and programmable in vivo genome editing, with an initial therapeutic focus on the precise collapse of pathogenic repeat expansions in neurodegenerative disease. Its unique two-site mechanism enables the seamless removal, repair, or insertion of both small and large DNA sequences, offering broad therapeutic potential, coupled with single AAV or all-RNA delivery. Dualase® achieves best-in-class accurate editing efficiency with undetectable off-target effects as demonstrated in preclinical cell and animal models at diverse targets and indications.
